Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1987-1-27
|
pubmed:abstractText |
A single agent systemic antibiotic (moxalactam) when used prophylactically in patients undergoing colon surgery was associated with a wound infection rate comparable to that achieved by a combination of oral neomycin and intravenous metronidazole. The data obtained demonstrated that the reduced infection rate was not the result of a reduction in the bacterial content of the colon alone but due to the prophylactic agents used for elective colon surgery.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0039-6060
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3541267-Aged,
pubmed-meshheading:3541267-Clinical Trials as Topic,
pubmed-meshheading:3541267-Colon,
pubmed-meshheading:3541267-Drug Therapy, Combination,
pubmed-meshheading:3541267-Humans,
pubmed-meshheading:3541267-Metronidazole,
pubmed-meshheading:3541267-Moxalactam,
pubmed-meshheading:3541267-Neomycin,
pubmed-meshheading:3541267-Prospective Studies,
pubmed-meshheading:3541267-Random Allocation,
pubmed-meshheading:3541267-Surgical Wound Infection
|
pubmed:year |
1987
|
pubmed:articleTitle |
Moxalactam as single-agent prophylaxis in the prevention of wound infection following colon surgery.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|